CLINICAL TRIALS PROFILE FOR VANCENASE AQ
All Clinical Trials for VANCENASE AQ
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00489203 ↗ | Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer | Completed | Fred Hutchinson Cancer Research Center | Phase 2 | 2007-04-01 | RATIONALE: Beclomethasone dipropionate may be effective in preventing acute graft-versus-host disease in patients undergoing a stem cell transplant for hematologic cancer. PURPOSE: This randomized phase II trial is studying how well beclomethasone dipropionate works in preventing acute graft-versus-host disease in patients undergoing a donor stem cell transplant for hematologic cancer. |
| NCT03855189 ↗ | Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | 1993-08-23 | The objectives of this study are to determine the safety and efficacy in seasonal allergic rhinitis of a four-week course of mometasone furoate compared to beclomethasone dipropionate or placebo. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VANCENASE AQ
Condition Name
Clinical Trial Locations for VANCENASE AQ
Trials by Country
Clinical Trial Progress for VANCENASE AQ
Clinical Trial Phase
Clinical Trial Sponsors for VANCENASE AQ
Sponsor Name
